COVID-19 RAPID TESTS

The COVID-19 antigen rapid test device is a lateral flow in vitro immunoassay intended to be used for the qualitative detection of the SARS-CoV-2 viral nucleoprotein. This device will detect both viable and nonviable virus from the nasal swab.

Kit Contains:
20 – Test Cassettes
20 – Nasal Swabs
20 – Pre-loaded buffer vials
1 – Vial Holder
1 – Product insert

Detect the presence of SARS-CoV-2 IgM and IgG antibodies instantly from a blood sample collected from a minimally-invasive fingerstick blood collection process.

Kit Contains:
20 – Test cassettes
20 – 10 uL pipettes
20 – Alcohol wipes
20 – One-time-use safety lancets (automatic spring loaded with retractable blade)
20 – Individual pouches of buffer
1 – Product insert

The BD Veritor™ Plus system provides objective, lab-quality immunoassay test results for healthcare providers and laboratorians in physician offices, clinics, hospitals and IDNs—within minutes. The system streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. It can also help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV) and group A strep while the patient is still on site, which may facilitate decision making for earlier intervention.

The BD Veritor™ System for Rapid Detection of SARS‑CoV‑2 antigen test detects proteins from the SARS‑CoV‑2 virus. A nasal swab is used to collect the specimen from a patient suspected of having COVID‑19. The sample is prepared, added to the assay cartridge and then interpreted by the Analyzer.

Kit Contains:
30 – Test Cassettes
30 – Nasal Swabs
30 – Pre-loaded buffer vials
1 – Product insert